Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Fc Protein and Glycoengineered Antibodies
Revenue, means the sales value of Fc Protein and Glycoengineered Antibodies
This report studies Fc Protein and Glycoengineered Antibodies in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Roche
TG Therapeutics
MedImmune/AstraZeneca
LFB Biotechnologies
Glycotope
Mentrik Biotech
MacroGenics
MorphoSys
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by Application, this report focuses on consumption, market share and growth rate of Fc Protein and Glycoengineered Antibodies in each application, can be divided into
Application 1
Application 2
Application 3
China Fc Protein and Glycoengineered Antibodies Market Research Report 2016
1 Fc Protein and Glycoengineered Antibodies Market Overview
1.1 Product Overview and Scope of Fc Protein and Glycoengineered Antibodies
1.2 Fc Protein and Glycoengineered Antibodies Segment by Type
1.2.1 China Production Market Share of Fc Protein and Glycoengineered Antibodies Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Applications of Fc Protein and Glycoengineered Antibodies
1.3.1 Fc Protein and Glycoengineered Antibodies Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 China Market Size (Value) of Fc Protein and Glycoengineered Antibodies (2011-2021)
1.5 China Fc Protein and Glycoengineered AntibodiesStatus and Outlook
1.6 Government Policies
2 China Fc Protein and Glycoengineered Antibodies Market Competition by Manufacturers
2.1 China Fc Protein and Glycoengineered Antibodies Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Fc Protein and Glycoengineered Antibodies Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Fc Protein and Glycoengineered Antibodies Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Fc Protein and Glycoengineered Antibodies Manufacturing Base Distribution, Sales Area, Product Type
2.5 Fc Protein and Glycoengineered Antibodies Market Competitive Situation and Trends
2.5.1 Fc Protein and Glycoengineered Antibodies Market Concentration Rate
2.5.2 Fc Protein and Glycoengineered Antibodies Market Share of Top 3 and Top 5 Manufacturers
3 China Fc Protein and Glycoengineered Antibodies Manufacturers Profiles/Analysis
3.1 Roche
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Fc Protein and Glycoengineered Antibodies Product Type, Application and Specification
3.1.2.1 Type I
3.1.2.2 Type II
3.1.3 Roche Fc Protein and Glycoengineered Antibodies Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 TG Therapeutics
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 124 Product Type, Application and Specification
3.2.2.1 Type I
3.2.2.2 Type II
3.2.3 TG Therapeutics 124 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 MedImmune/AstraZeneca
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 133 Product Type, Application and Specification
3.3.2.1 Type I
3.3.2.2 Type II
3.3.3 MedImmune/AstraZeneca 133 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 LFB Biotechnologies
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Oct Product Type, Application and Specification
3.4.2.1 Type I
3.4.2.2 Type II
3.4.3 LFB Biotechnologies Oct Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Glycotope
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Product Type, Application and Specification
3.5.2.1 Type I
3.5.2.2 Type II
3.5.3 Glycotope Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Mentrik Biotech
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Million USD Product Type, Application and Specification
3.6.2.1 Type I
3.6.2.2 Type II
3.6.3 Mentrik Biotech Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 MacroGenics
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Pharma & Healthcare Product Type, Application and Specification
3.7.2.1 Type I
3.7.2.2 Type II
3.7.3 MacroGenics Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 MorphoSys
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Product Type, Application and Specification
3.8.2.1 Type I
3.8.2.2 Type II
3.8.3 MorphoSys Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
4 China Fc Protein and Glycoengineered Antibodies Capacity, Production, Revenue, Consumption, Export and Import (2011-2016)
4.1 China Fc Protein and Glycoengineered Antibodies Capacity, Production and Growth (2011-2016)
4.2 China Fc Protein and Glycoengineered Antibodies Revenue and Growth (2011-2016)
4.3 China Fc Protein and Glycoengineered Antibodies Production, Consumption, Export and Import (2011-2016)
5 China Fc Protein and Glycoengineered Antibodies Production, Revenue (Value), Price Trend by Type
5.1 China Fc Protein and Glycoengineered Antibodies Production and Market Share by Type (2011-2016)
5.2 China Fc Protein and Glycoengineered Antibodies Revenue and Market Share by Type (2011-2016)
5.3 China Fc Protein and Glycoengineered Antibodies Price by Type (2011-2016)
5.4 China Fc Protein and Glycoengineered Antibodies Production Growth by Type (2011-2016)
6 China Fc Protein and Glycoengineered Antibodies Market Analysis by Application
6.1 China Fc Protein and Glycoengineered Antibodies Consumption and Market Share by Application (2011-2016)
6.2 China Fc Protein and Glycoengineered Antibodies Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries
7 Fc Protein and Glycoengineered Antibodies Manufacturing Cost Analysis
7.1 Fc Protein and Glycoengineered Antibodies Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Fc Protein and Glycoengineered Antibodies
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Fc Protein and Glycoengineered Antibodies Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Fc Protein and Glycoengineered Antibodies Major Manufacturers in 2015
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 China Fc Protein and Glycoengineered Antibodies Market Forecast (2016-2021)
11.1 China Fc Protein and Glycoengineered Antibodies Capacity, Production, Revenue Forecast (2016-2021)
11.2 China Fc Protein and Glycoengineered Antibodies Production, Import, Export and Consumption Forecast (2016-2021)
11.3 China Fc Protein and Glycoengineered Antibodies Production Forecast by Type (2016-2021)
11.4 China Fc Protein and Glycoengineered Antibodies Consumption Forecast by Application (2016-2021)
11.5 Fc Protein and Glycoengineered Antibodies Price Forecast (2016-2021)
12 Research Findings and Conclusion
13 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
Figure Picture of Fc Protein and Glycoengineered Antibodies
Figure China Production Market Share of Fc Protein and Glycoengineered Antibodies by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Fc Protein and Glycoengineered Antibodies Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure China Fc Protein and Glycoengineered Antibodies Revenue (Million USD) and Growth Rate (2011-2021)
Table China Fc Protein and Glycoengineered Antibodies Capacity of Key Manufacturers (2015 and 2016)
Table China Fc Protein and Glycoengineered Antibodies Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Fc Protein and Glycoengineered Antibodies Capacity of Key Manufacturers in 2015
Figure China Fc Protein and Glycoengineered Antibodies Capacity of Key Manufacturers in 2016
Table China Fc Protein and Glycoengineered Antibodies Production of Key Manufacturers (2015 and 2016)
Table China Fc Protein and Glycoengineered Antibodies Production Share by Manufacturers (2015 and 2016)
Figure 2015 Fc Protein and Glycoengineered Antibodies Production Share by Manufacturers
Figure 2016 Fc Protein and Glycoengineered Antibodies Production Share by Manufacturers
Table China Fc Protein and Glycoengineered Antibodies Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Fc Protein and Glycoengineered Antibodies Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Fc Protein and Glycoengineered Antibodies Revenue Share by Manufacturers
Table 2016 China Fc Protein and Glycoengineered Antibodies Revenue Share by Manufacturers
Table China Market Fc Protein and Glycoengineered Antibodies Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Fc Protein and Glycoengineered Antibodies Average Price of Key Manufacturers in 2015
Table Manufacturers Fc Protein and Glycoengineered Antibodies Manufacturing Base Distribution and Sales Area
Table Manufacturers Fc Protein and Glycoengineered Antibodies Product Type
Figure Fc Protein and Glycoengineered Antibodies Market Share of Top 3 Manufacturers
Figure Fc Protein and Glycoengineered Antibodies Market Share of Top 5 Manufacturers
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Fc Protein and Glycoengineered Antibodies Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Fc Protein and Glycoengineered Antibodies Market Share (2011-2016)
Table TG Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table TG Therapeutics Fc Protein and Glycoengineered Antibodies Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure TG Therapeutics Fc Protein and Glycoengineered Antibodies Market Share (2011-2016)
Table MedImmune/AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table MedImmune/AstraZeneca Fc Protein and Glycoengineered Antibodies Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure MedImmune/AstraZeneca Fc Protein and Glycoengineered Antibodies Market Share (2011-2016)
Table LFB Biotechnologies Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table LFB Biotechnologies Fc Protein and Glycoengineered Antibodies Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure LFB Biotechnologies Fc Protein and Glycoengineered Antibodies Market Share (2011-2016)
Table Glycotope Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Glycotope Fc Protein and Glycoengineered Antibodies Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Glycotope Fc Protein and Glycoengineered Antibodies Market Share (2011-2016)
Table Mentrik Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mentrik Biotech Fc Protein and Glycoengineered Antibodies Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Mentrik Biotech Fc Protein and Glycoengineered Antibodies Market Share (2011-2016)
Table MacroGenics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table MacroGenics Fc Protein and Glycoengineered Antibodies Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure MacroGenics Fc Protein and Glycoengineered Antibodies Market Share (2011-2016)
Table MorphoSys Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table MorphoSys Fc Protein and Glycoengineered Antibodies Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure MorphoSys Fc Protein and Glycoengineered Antibodies Market Share (2011-2016)
Figure China Fc Protein and Glycoengineered Antibodies Capacity, Production and Growth (2011-2016)
Figure China Fc Protein and Glycoengineered Antibodies Revenue (Million USD) and Growth (2011-2016)
Table China Fc Protein and Glycoengineered Antibodies Production, Consumption, Export and Import (2011-2016)
Table China Fc Protein and Glycoengineered Antibodies Production by Type (2011-2016)
Table China Fc Protein and Glycoengineered Antibodies Production Share by Type (2011-2016)
Figure Production Market Share of Fc Protein and Glycoengineered Antibodies by Type (2011-2016)
Figure 2015 Production Market Share of Fc Protein and Glycoengineered Antibodies by Type
Table China Fc Protein and Glycoengineered Antibodies Revenue by Type (2011-2016)
Table China Fc Protein and Glycoengineered Antibodies Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Fc Protein and Glycoengineered Antibodies by Type (2011-2016)
Figure 2015 Revenue Market Share of Fc Protein and Glycoengineered Antibodies by Type
Table China Fc Protein and Glycoengineered Antibodies Price by Type (2011-2016)
Figure China Fc Protein and Glycoengineered Antibodies Production Growth by Type (2011-2016)
Table China Fc Protein and Glycoengineered Antibodies Consumption by Application (2011-2016)
Table China Fc Protein and Glycoengineered Antibodies Consumption Market Share by Application (2011-2016)
Figure China Fc Protein and Glycoengineered Antibodies Consumption Market Share by Application in 2015
Table China Fc Protein and Glycoengineered Antibodies Consumption Growth Rate by Application (2011-2016)
Figure China Fc Protein and Glycoengineered Antibodies Consumption Growth Rate by Application (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Fc Protein and Glycoengineered Antibodies
Figure Manufacturing Process Analysis of Fc Protein and Glycoengineered Antibodies
Figure Fc Protein and Glycoengineered Antibodies Industrial Chain Analysis
Table Raw Materials Sources of Fc Protein and Glycoengineered Antibodies Major Manufacturers in 2015
Table Major Buyers of Fc Protein and Glycoengineered Antibodies
Table Distributors/Traders List
Figure China Fc Protein and Glycoengineered Antibodies Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate Forecast (2016-2021)
Table China Fc Protein and Glycoengineered Antibodies Production, Import, Export and Consumption Forecast (2016-2021)
Table China Fc Protein and Glycoengineered Antibodies Production Forecast by Type (2016-2021)
Table China Fc Protein and Glycoengineered Antibodies Consumption Forecast by Application (2016-2021)
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...